ArticlePharmaceutics2022

Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model.

Mai Hazekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.